Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -14.78% is 60% above its 5-year average of -36.97%, near the high end of its 5-year range (-73.96%–-6.78%).
22.73% above its 12-month average of -19.13%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -23.36%.
NET PROFIT MARGIN
-14.78%
NET PROFIT MARGIN AVG TTM
-19.13%
NET PROFIT MARGIN AVG 3Y
-34.81%
NET PROFIT MARGIN AVG 5Y
-36.97%
NET PROFIT MARGIN AVG 10Y
-36.84%
NET PROFIT MARGIN AVG 15Y
-28.23%
NET PROFIT MARGIN AVG 20Y
-19.94%
CURRENT VS TTM AVG
+22.73%
CURRENT VS 3Y AVG
+57.54%
CURRENT VS 5Y AVG
+60.02%
CURRENT VS 10Y AVG
+59.88%
CURRENT VS 15Y AVG
+47.65%
CURRENT VS 20Y AVG
+25.87%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Apyx Medical Corporation
Market Cap
$108.64M
Net Profit Margin
-14.78%
TTM Avg
-19.13%
3Y Avg
-34.81%
5Y Avg
-36.97%
Market Cap
$108.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1332.08%
Market Cap
$109.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$107.44M
Net Profit Margin
31.95%
TTM Avg
15.97%
3Y Avg
7.99%
5Y Avg
5.33%
Market Cap
$107.28M
Net Profit Margin
-33.92%
TTM Avg
-11.74%
3Y Avg
-13.15%
5Y Avg
-11.88%
Market Cap
$110.05M
Net Profit Margin
-4416.22%
TTM Avg
-2208.11%
3Y Avg
-1104.06%
5Y Avg
-736.04%
Market Cap
$111.14M
Net Profit Margin
-52.59%
TTM Avg
-29.17%
3Y Avg
-18.36%
5Y Avg
-9.63%
Market Cap
$105.48M
Net Profit Margin
-72.28%
TTM Avg
-110.67%
3Y Avg
-76.27%
5Y Avg
-63.46%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $108.64M | -14.78% | -19.13% | -34.81% | -36.97% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.29M | 0.00% | 0.00% | 0.00% | -1332.08% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Immunic, Inc. (IMUX)vs › | $107.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | 31.95% | 15.97% | 7.99% | 5.33% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.28M | -33.92% | -11.74% | -13.15% | -11.88% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.05M | -4416.22% | -2208.11% | -1104.06% | -736.04% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -52.59% | -29.17% | -18.36% | -9.63% |
| Definitive Healthcare Corp. (DH)vs › | $105.48M | -72.28% | -110.67% | -76.27% | -63.46% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.30M | -270.22% | -342.92% | -204.73% | -136.49% |
Operating Margin
-6.1%
Net Profit Margin
-14.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -23.36% |
| 2026-03-31 | -16.88% |
| 2025-12-31 | -6.78% |
| 2025-09-30 | -15.41% |
| 2025-06-30 | -33.22% |
| 2025-03-31 | -44.01% |
| 2024-12-31 | -32.54% |
| 2024-09-30 | -40.94% |
| 2024-06-30 | -53.96% |
| 2024-03-31 | -73.96% |
| 2023-12-31 | -65.52% |
| 2023-09-30 | -38.65% |
| 2023-06-30 | -7.33% |
| 2023-03-31 | -28.69% |
| 2022-12-31 | -47.97% |
| 2022-09-30 | -63.24% |
| 2022-06-30 | -52.72% |
| 2022-03-31 | -47.59% |
| 2021-12-31 | -11.91% |
| 2021-09-30 | -35.69% |
| 2021-06-30 | -36.05% |
| 2021-03-31 | -56.74% |
| 2020-12-31 | -13.32% |
| 2020-09-30 | -53.61% |
| 2020-06-30 | -109.17% |
| 2020-03-31 | -39.04% |
| 2019-12-31 | -68.60% |
| 2019-09-30 | -56.91% |
| 2019-06-30 | -66.05% |
| 2019-03-31 | -80.39% |
| 2018-12-31 | -66.79% |
| 2018-09-30 | 1883.82% |
| 2018-06-30 | -2.37% |
| 2018-03-31 | -9.43% |
| 2017-12-31 | -7.26% |
| 2017-09-30 | -13.32% |
| 2017-06-30 | -13.35% |
| 2017-03-31 | -20.09% |
| 2016-12-31 | -5.51% |
| 2016-09-30 | -9.58% |
| 2016-06-30 | -5.58% |
| 2016-03-31 | -25.00% |
| 2015-12-31 | -17.00% |
| 2015-09-30 | -20.29% |
| 2015-06-30 | -20.58% |
| 2015-03-31 | -14.30% |
| 2014-12-31 | -69.51% |
| 2014-09-30 | -40.28% |
| 2014-06-30 | 3.61% |
| 2014-03-31 | -148.21% |
| 2013-12-31 | -40.29% |
| 2013-09-30 | -5.89% |
| 2013-06-30 | -18.52% |
| 2013-03-31 | -7.18% |
| 2012-12-31 | 4.19% |
| 2012-09-30 | -0.10% |
| 2012-06-30 | 2.04% |
| 2012-03-31 | 2.78% |
| 2011-12-31 | -14.21% |
| 2011-09-30 | 1.01% |
| 2011-06-30 | 6.27% |
| 2011-03-31 | 7.99% |
| 2010-12-31 | -21.97% |
| 2010-09-30 | 0.07% |
| 2010-06-30 | 0.95% |
| 2010-03-31 | -4.03% |
| 2009-12-31 | 0.42% |
| 2009-09-30 | -0.59% |
| 2009-06-30 | 3.03% |
| 2009-03-31 | 5.59% |
| 2008-12-31 | 0.54% |
| 2008-09-30 | 5.02% |
| 2008-06-30 | 20.47% |
| 2008-03-31 | 2.85% |
| 2007-12-31 | 3.91% |
| 2007-09-30 | 6.32% |
| 2007-06-30 | 14.36% |
| 2007-03-31 | 8.65% |
| 2006-12-31 | 6.11% |
| 2006-09-30 | 12.24% |
| 2006-06-30 | 10.57% |
| 2006-03-31 | 11.48% |
| 2005-12-31 | 4.91% |
| 2005-09-30 | 3.41% |
| 2005-06-30 | -2.39% |
| 2005-03-31 | 1.88% |
| 2004-12-31 | 7.09% |
| 2004-09-30 | 9.31% |
| 2004-06-30 | 7.69% |
| 2004-03-31 | 5.06% |
| 2003-12-31 | -6.28% |
| 2003-09-30 | 9.80% |
| 2003-06-30 | 10.60% |
| 2003-03-31 | 1.54% |
| 2002-12-31 | -10.75% |
| 2002-09-30 | -2.12% |
